Acute Kidney Injury - Nursing Case Study

Pathophysiology

• Primary mechanism: Ischemia-induced acute tubular necrosis (ATN) - Reduced renal perfusion due to hypotension or vascular obstruction leads to diminished oxygen delivery, causing tubular epithelial cell injury and death, impairing reabsorption and filtration processes.

• Secondary mechanism: Nephrotoxic injury - Exposure to nephrotoxic agents (e.g., certain medications, contrast media) causes direct tubular epithelial damage, leading to cell necrosis, tubular obstruction, and back-leakage of filtrate, exacerbating renal dysfunction.

• Key complication: Oliguria and fluid overload - Resulting from compromised glomerular filtration rate (GFR) and tubular function, leading to electrolyte imbalances, metabolic acidosis, and potential progression to chronic kidney disease (CKD) if unresolved.

Patient Profile

Demographics:

65-year-old male, retired chemical engineer

History:

• Key past medical history: Type 2 Diabetes Mellitus, Hypertension, Coronary Artery Disease, Chronic Obstructive Pulmonary Disease

• Current medications: Metformin, Lisinopril, Atorvastatin, Albuterol inhaler, Aspirin

• Allergies: Penicillin

Current Presentation:

• Chief complaint: Decreased urine output and shortness of breath

• Key symptoms: Edema, confusion, fatigue, nausea

• Vital signs: Blood Pressure: 90/60 mmHg, Heart Rate: 120 bpm, Respiratory Rate: 28 breaths per minute, Temperature: 101.3°F, Oxygen Saturation: 85% on room air

Section 1

As the medical team initiates a comprehensive assessment, several critical findings emerge. Physical examination reveals marked peripheral edema, particularly in the lower extremities and sacral area, consistent with fluid overload. Auscultation of the lungs shows bilateral crackles, suggesting pulmonary congestion. The patient's mental status is altered, with episodes of confusion and disorientation, likely due to uremic encephalopathy exacerbated by metabolic acidosis. Despite the administration of supplemental oxygen, his oxygen saturation remains suboptimal at 88%, indicating significant respiratory compromise.

Laboratory results further delineate the severity of the acute kidney injury. Serum creatinine levels have escalated to 4.5 mg/dL from a baseline of 1.2 mg/dL, and blood urea nitrogen (BUN) is markedly elevated at 80 mg/dL, reflecting significant renal impairment. Electrolyte imbalances are evident, with hyperkalemia at 6.3 mEq/L and hyponatremia at 128 mEq/L, both of which pose immediate risks for cardiac dysrhythmias and neurological sequelae. Arterial blood gas analysis shows a pH of 7.28, bicarbonate of 16 mEq/L, and PaCO2 of 32 mmHg, confirming metabolic acidosis with compensatory respiratory alkalosis. An urgent electrocardiogram (ECG) reveals peaked T-waves and widened QRS complexes, underscoring the need for prompt intervention to address the hyperkalemia.

In response to the acute findings, the healthcare team faces a complex decision-making scenario. The immediate priority is to stabilize the hemodynamic status. Intravenous fluids are cautiously administered to improve renal perfusion while closely monitoring for exacerbation of pulmonary edema. Concurrently, measures to correct hyperkalemia are implemented, including calcium gluconate for cardiac membrane stabilization, insulin with dextrose to facilitate cellular uptake of potassium, and sodium bicarbonate to combat acidosis. The possibility of renal replacement therapy, such as dialysis, is considered for severe electrolyte disturbances and fluid overload. The patient's response to these interventions will be critical in determining the next steps, as ongoing monitoring and adjustment of the treatment plan are essential in avoiding progression to chronic kidney disease.

Section 2

As the medical team continues to monitor the patient's status, new complications arise, necessitating further critical thinking and clinical judgment. Despite initial interventions, the patient's respiratory condition deteriorates. Oxygen saturation drops to 85%, and respiratory rate increases to 32 breaths per minute, indicating worsening pulmonary edema and respiratory distress. An urgent chest X-ray confirms extensive bilateral infiltrates, consistent with acute pulmonary edema. Meanwhile, auscultation reveals decreased breath sounds at the bases, suggesting possible atelectasis or pleural effusion, complicating the respiratory picture.

The patient's cardiovascular status also shows signs of compromise. Blood pressure fluctuates, with readings as low as 90/60 mmHg, indicative of potential hypoperfusion and shock. Heart rate is irregular at 120 beats per minute, raising concerns about an evolving arrhythmia, likely secondary to persistent hyperkalemia and metabolic derangements. Repeat ECG shows worsening QRS widening and new ST-segment changes, prompting the team to escalate treatment for hyperkalemia and consider antiarrhythmic therapy.

Laboratory tests reveal that despite initial treatments, hyperkalemia persists with a potassium level of 6.1 mEq/L, and metabolic acidosis remains severe, with a pH of 7.25 and bicarbonate of 15 mEq/L. These findings, coupled with the patient's declining respiratory and cardiovascular status, necessitate urgent renal replacement therapy. The team prepares for emergent dialysis, aiming to rapidly remove excess fluid, correct electrolyte imbalances, and stabilize the patient's condition. The decision to initiate dialysis requires careful coordination and continuous assessment to prevent further complications and support renal recovery.

Section 3

Change in Patient Status

As the medical team initiates renal replacement therapy, the patient exhibits an acute change in mental status, becoming increasingly lethargic and disoriented. This sudden neurological decline raises concerns about uremic encephalopathy, given the persistently elevated blood urea nitrogen (BUN) level of 95 mg/dL and creatinine of 6.8 mg/dL. Simultaneously, the patient exhibits signs of peripheral vasodilation, with skin that is warm and flushed, indicating the possibility of sepsis or a systemic inflammatory response. The team swiftly orders blood cultures and initiates broad-spectrum antibiotics, suspecting an underlying infection as a complicating factor in this multifaceted clinical scenario.

Despite the initiation of dialysis, the patient's hemodynamic status remains precarious. Blood pressure continues to waver, dropping to a critical low of 85/55 mmHg, despite aggressive fluid resuscitation and vasopressor support. The echocardiogram performed at the bedside reveals a reduced ejection fraction of 35%, suggesting acute heart failure or myocardial stunning, possibly secondary to the metabolic derangements and electrolyte imbalances. This finding necessitates careful titration of inotropic agents to support cardiac output while managing the delicate balance of fluid overload and renal perfusion.

As these events unfold, the interdisciplinary team must employ advanced clinical reasoning to reassess the treatment plan. They consider the need for continuous renal replacement therapy (CRRT) to allow for more precise fluid and electrolyte management, given the patient's tenuous cardiovascular state. The evolving picture of multi-organ dysfunction requires ongoing vigilance, as the team anticipates potential further complications such as disseminated intravascular coagulation (DIC) or acute liver injury, both of which could further complicate the patient's already critical condition.

Section 4

As the medical team continues to navigate the complexities of the patient's condition, new diagnostic results provide additional insights into the underlying issues. Blood cultures return positive for gram-negative rods, confirming a septic process likely responsible for the initial systemic inflammatory response. This finding correlates with the patient's elevated lactate level of 4.5 mmol/L, indicating significant tissue hypoperfusion and heightened metabolic stress. Meanwhile, the patient's liver function tests reveal concerning elevations, with an AST of 285 U/L and ALT of 310 U/L, suggestive of acute liver injury, possibly due to hypoperfusion or direct infectious insult.

In response to these new diagnostic revelations, the team intensifies antimicrobial therapy, tailoring antibiotic coverage based on the susceptibility profile of the identified pathogen. Despite these efforts, the patient's clinical status remains critical, with persistent hypotension and oliguria despite optimized fluid management and titration of vasopressors. The patient's respiratory status also deteriorates, with an increased respiratory rate of 30 breaths per minute and worsening hypoxemia, as evidenced by an arterial blood gas analysis showing a pH of 7.28, PaCO2 of 55 mmHg, and PaO2 of 60 mmHg on 50% FiO2. This respiratory compromise necessitates the initiation of mechanical ventilation to ensure adequate oxygenation and support the failing respiratory system.

The team faces the daunting task of managing the interplay between multi-organ dysfunctions, considering the potential for progressive DIC, as suggested by a rising D-dimer level and prolonged prothrombin time. Continuous renal replacement therapy (CRRT) is commenced to provide steady fluid and metabolic control, aiming to stabilize electrolyte imbalances and support renal function. The patient's journey remains fraught with challenges, demanding vigilant monitoring and dynamic adjustments to the treatment plan, as the team anticipates possible further complications and strives to prevent cascading organ failures.

Section 5

New Complications

As the medical team continues to provide intensive care, new complications emerge that further complicate the patient's clinical picture. Approximately 12 hours after the initiation of mechanical ventilation and CRRT, the patient's cardiovascular status shows signs of further deterioration. A sudden increase in heart rate to 145 bpm, coupled with a drop in blood pressure to 82/48 mmHg despite maximum vasopressor support, raises concern for evolving cardiogenic shock. An urgent bedside echocardiogram reveals severely reduced left ventricular ejection fraction, indicative of acute stress-induced cardiomyopathy, possibly exacerbated by the ongoing septic state and metabolic derangements. This new cardiac complication necessitates the introduction of inotropic support to improve myocardial contractility and maintain hemodynamic stability.

Concurrently, the patient's neurological status exhibits alarming changes. The Glasgow Coma Scale score decreases to 8, indicating a severe alteration in consciousness. Neurological examination reveals sluggish pupillary response and decreased spontaneous movements, suggesting potential cerebral hypoperfusion or metabolic encephalopathy. A stat CT scan of the head is ordered to rule out acute intracranial events, while serum ammonia levels are checked to evaluate for hepatic encephalopathy secondary to acute liver dysfunction. These developments prompt the team to reassess sedation and analgesia management, ensuring that the patient's neurological decline is not drug-induced while maintaining adequate comfort and minimizing further neurological compromise.

In light of these emerging complications, the medical team is prompted to re-evaluate the comprehensive management strategy, balancing the need for aggressive organ support with the risk of additional iatrogenic harm. The interdisciplinary team, including cardiology, nephrology, and neurology consultants, collaborates closely to address the multifaceted challenges, aiming to optimize cardiac function, stabilize hemodynamics, and preserve neurological integrity. The patient's condition remains precarious, demanding continuous reassessment and adaptation of interventions in a concerted effort to avert further organ failures and guide the patient towards stabilization.